SciSparc Ltd. (SPRC)
NASDAQ: SPRC · IEX Real-Time Price · USD
1.400
-0.020 (-1.41%)
At close: Apr 30, 2024, 4:00 PM
1.408
+0.008 (0.57%)
After-hours: Apr 30, 2024, 5:34 PM EDT
SciSparc Revenue
In the year 2023, SciSparc had annual revenue of $793.11K with 108.44% growth.
Revenue (ttm)
$793.11K
Revenue Growth
+108.44%
P/S Ratio
1.19
Revenue / Employee
$959,667
Employees
3
Market Cap
3.43M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 793.11K | 412.61K | 108.44% |
Dec 31, 2022 | 380.51K | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Applied DNA Sciences | 9.00M |
Evoke Pharma | 5.18M |
Helius Medical Technologies | 644.00K |
Aethlon Medical | 574.25K |
Finch Therapeutics Group | 107.00K |
SPRC News
- 19 days ago - SciSparc to Acquire AutoMax - GlobeNewsWire
- 4 weeks ago - SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression - GlobeNewsWire
- 5 weeks ago - SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research - GlobeNewsWire
- 6 weeks ago - SciSparc Granted Another Patent, Strengthening its Core Technology in Canada - GlobeNewsWire
- 6 weeks ago - SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial - GlobeNewsWire
- 7 weeks ago - SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure - GlobeNewsWire
- 7 weeks ago - SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder - GlobeNewsWire
- 7 weeks ago - SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe - GlobeNewsWire